title: Contact allergies in haemodialysis patients: a prospective study of 75 patients.
abstract: BACKGROUND
  Haemodialysis exposes patients to many potentially sensitizing allergens.
  
  
  OBJECTIVE
  The primary objective of this study was to evaluate the prevalence of delayed hypersensitivity in a population of haemodialysis patients. Secondary objectives were to identify the possible risk factors for contact sensitization and to propose a series of skin tests adapted to haemodialysis patients.
  
  
  METHODS
  A prospective monocentric study was carried out in a nonselected population of haemodialysis patients. For each patient, medical history of atopy and allergic contact dermatitis, ongoing treatments (including topical ones), presence of eczema at the site of vascular access for haemodialysis were recorded. Allergological investigation included delayed hypersensitivity tests (European Environmental and Contact Dermatitis Research Group battery, tests GERDA, additional list and a battery of antiseptics and other dialysis-specific allergens) and latex skin prick test.
  
  
  RESULTS
  Seventy-five patients (41 men, 34 women, mean age of 65 years old), with a mean 3.8 years under dialysis, were included. Nineteen patients (25%) had at least one positive skin test and 13 (17%) a positive patch test to at least one allergen relative to dialysis process including eight tests to lidocaine-prilocaine cream and three to povidone-iodine. Tests results seemed clinically relevant since nine patients had localized pruritus at the fistula site and six patients active eczema around it.
  
  
  CONCLUSIONS
  Contact sensitizations are frequent in haemodialysis patients and are linked to vascular access conditioning especially the use of lidocaine-prilocaine cream. Designing a specific test battery could help to diagnose the potential allergens and subsequently to give advice to avoid contact with sensitizing agents.
authors.affiliation: Department of Dermatology, Hôpital Sainte Marguerite, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Gaudy-Marqueste
authors.forename: C
authors.initials: C
authors.lastname: Jouhet
authors.forename: M
authors.initials: M
authors.lastname: Castelain
authors.forename: P
authors.initials: P
authors.lastname: Brunet
authors.forename: Y
authors.initials: Y
authors.lastname: Berland
authors.forename: J J
authors.initials: JJ
authors.lastname: Grob
authors.forename: M A
authors.initials: MA
authors.lastname: Richard
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000485:Allergens / Q000276:immunology; D017449:Dermatitis, Allergic Contact / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D015995:Prevalence; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D000485:Allergens; D007073:Immunoglobulin E